Acelyrin Statistics
Total Valuation
Acelyrin has a market cap or net worth of $261.85 million. The enterprise value is -$178.73 million.
Important Dates
The last earnings date was Wednesday, March 19, 2025, after market close.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Acelyrin has 100.71 million shares outstanding. The number of shares has increased by 41.35% in one year.
| Current Share Class | 100.71M |
| Shares Outstanding | 100.71M |
| Shares Change (YoY) | +41.35% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 3.11% |
| Owned by Institutions (%) | 84.45% |
| Float | 73.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.10, with a Debt / Equity ratio of 0.02.
| Current Ratio | 18.10 |
| Quick Ratio | 17.08 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.54% and return on invested capital (ROIC) is -32.66%.
| Return on Equity (ROE) | -44.54% |
| Return on Assets (ROA) | -29.73% |
| Return on Invested Capital (ROIC) | -32.66% |
| Return on Capital Employed (ROCE) | -63.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.99M |
| Employee Count | 83 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.48% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 4.18 |
| Relative Strength Index (RSI) | 50.38 |
| Average Volume (20 Days) | 1,085,655 |
Short Selling Information
The latest short interest is 4.68 million, so 4.65% of the outstanding shares have been sold short.
| Short Interest | 4.68M |
| Short Previous Month | 4.30M |
| Short % of Shares Out | 4.65% |
| Short % of Float | 6.39% |
| Short Ratio (days to cover) | 1.78 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -293.46M |
| Pretax Income | -240.16M |
| Net Income | -248.23M |
| EBITDA | -293.04M |
| EBIT | -293.46M |
| Earnings Per Share (EPS) | -$2.50 |
Full Income StatementBalance Sheet
The company has $447.88 million in cash and $7.30 million in debt, giving a net cash position of $440.58 million or $4.37 per share.
| Cash & Cash Equivalents | 447.88M |
| Total Debt | 7.30M |
| Net Cash | 440.58M |
| Net Cash Per Share | $4.37 |
| Equity (Book Value) | 458.29M |
| Book Value Per Share | 4.56 |
| Working Capital | 454.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$303.92 million and capital expenditures -$1.25 million, giving a free cash flow of -$305.17 million.
| Operating Cash Flow | -303.92M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | -305.17M |
| FCF Per Share | -$3.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |